TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34798039 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33955109 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33955109 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33955109 — Predictive Biomarker (PRD): Hormone receptor
Study 33227549 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 34887446 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 32145372 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 33810258 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 33810258 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32523337 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36208718 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33733338 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 32689756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32689756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32689756 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32689756 — Safety Biomarker (SAF): IL-6 and IL-10
Study 35365036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35365036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35365036 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33330958 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34793832 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 34793832 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33464336 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 36207846 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 36207846 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 36207846 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 36207846 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 36207846 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34380842 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32034019 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34980596 — Surrogate Endpoint (SUR): Blood pressure
Study 35344649 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35994324 — Surrogate Endpoint (SUR): Blood pressure
Study 32370806 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study 32370806 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32370806 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study 32370806 — Surrogate Endpoint (SUR): Bone mineral density
Study 34904798 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34099646 — Predictive Biomarker (PRD): STAT4 mRNA
Genes: STAT4
Study 34099646 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32902389 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35814782 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 35124909 — Surrogate Endpoint (SUR): Serum creatinine
Study 33692375 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 34280999 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 34280999 — Predictive Biomarker (PRD): PCSK7 mRNA
Genes: PCSK7; LPC; PC7; PC8; SPC7
Study 33903855 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study 35219302 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32636319 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 34730488 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32289714 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study 36058230 — Surrogate Endpoint (SUR): Blood pressure
Study 37499590 — Surrogate Endpoint (SUR): Blood pressure
Study 35777455 — Surrogate Endpoint (SUR): Blood pressure
Study 32616128 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 35077042 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 32588050 — Surrogate Endpoint (SUR): Serum potassium
Study 34955432 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34955432 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 32150072 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32150072 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32379724 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 32379724 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 34591237 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33963012 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33963012 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 33963012 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 32980623 — Surrogate Endpoint (SUR): Blood pressure
Study 35323843 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35323843 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33569570 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 33569570 — Pharmacodynamic Biomarker (PDY): Beta-secretase 1
Genes: BACE1; BACE; KIAA1149
Study 32729923 — Surrogate Endpoint (SUR): Blood pressure
Study 33471739 — Surrogate Endpoint (SUR): Serum calcium
Study 35887534 — Surrogate Endpoint (SUR): Blood pressure
Study 32365226 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32365226 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35395734 — Surrogate Endpoint (SUR): Blood pressure
Study 32030780 — Predictive Biomarker (PRD): CST1 mRNA
Genes: CST1
Study 36297099 — Monitoring Biomarker (MOI): Cell-free DNA
Study 32111126 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 32035516 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32665479 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 34600734 — Surrogate Endpoint (SUR): Blood pressure
Study 34168284 — Surrogate Endpoint (SUR): Hematologic response
Study 34534429 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34419135 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32713721 — Surrogate Endpoint (SUR): Blood pressure
Study 32482712 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study 35752762 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study 34556318 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35109880 — Surrogate Endpoint (SUR): Blood pressure
Study 35109880 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35562778 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35698954 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35698954 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36141875 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 35078830 — Monitoring Biomarker (MOI): Procalcitonin
Study 35078830 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34544468 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33471654 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 33471654 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 33471654 — Surrogate Endpoint (SUR): Serum calcium
Study 35134995 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study 33150799 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 33998672 — Pharmacodynamic Biomarker (PDY): Fatty acid amide hydrolase 1
Genes: FAAH; FAAH1
Study 32069361 — Surrogate Endpoint (SUR): Bacterial count
Study 32377957 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34933684 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36044097 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 34580169 — Surrogate Endpoint (SUR): Blood pressure
Study 32016788 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33465316 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 34744069 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study 33737614 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32620339 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 32167863 — Predictive Biomarker (PRD): Microsatellite instability
Study 32005747 — Predictive Biomarker (PRD): PDCD1LG2 mRNA
Genes: PDCD1LG2; B7DC; CD273; PDCD1L2; PDL2
Study 32005747 — Predictive Biomarker (PRD): TYMP mRNA
Genes: TYMP; ECGF1
Study 35277071 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35141805 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35141805 — Safety Biomarker (SAF): BDNF
Study 34962984 — Surrogate Endpoint (SUR): Blood pressure
Study 35623863 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35623863 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35623863 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35623863 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35623863 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33049054 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 34475137 — Surrogate Endpoint (SUR): Blood pressure
Study 36469320 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 36469320 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36469320 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33453383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33453383 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33453383 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32779952 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34256716 — Surrogate Endpoint (SUR): Blood pressure
Study 35679127 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 32761668 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 32761668 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32761668 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 34171293 — Surrogate Endpoint (SUR): Blood pressure
Study 32216829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34528495 — Surrogate Endpoint (SUR): Blood pressure
Study 32959557 — Predictive Biomarker (PRD): ST7 mRNA
Genes: ST7; FAM4A1; HELG; RAY1
Study 32959557 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 32356074 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35896299 — Monitoring Biomarker (MOI): Cell-free DNA
Study 36370336 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 32535403 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32535403 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32535403 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32535403 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36307922 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 36307922 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33155876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33847663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33847663 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32732154 — Surrogate Endpoint (SUR): Blood pressure
Study 36349190 — Surrogate Endpoint (SUR): Blood pressure
Study 33188075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33188075 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 34147308 — Surrogate Endpoint (SUR): Serum potassium
Study 1986130709 — Surrogate Endpoint (SUR): Blood pressure
Study 34991693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35104066 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 35123016 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 35130342 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 35130342 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35130342 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 35130342 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study 35130342 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 33664157 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 34582701 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34972039 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33579288 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 33836476 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 34397028 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33651733 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32792358 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 32792358 — Predictive Biomarker (PRD): Microsatellite instability
Study 35380473 — Surrogate Endpoint (SUR): Blood pressure
Study 33676009 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 33994515 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 33549429 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33549429 — Predictive Biomarker (PRD): FBXO8 mRNA
Genes: FBXO8; FBS; FBX8; DC10; UNQ1877/PRO4320
Study 33549429 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33549429 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34905446 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35442771 — Safety Biomarker (SAF): Hyaluronic acid
Study 35745231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33631287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33631287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 33631287 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32592830 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33402161 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33715279 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 32071923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 32071923 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 32180131 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 36207894 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33358691 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study 35887238 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study 32085792 — Surrogate Endpoint (SUR): Blood pressure
Study 32085792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32085792 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32209338 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33199228 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36050657 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 36315843 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 36462609 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 36462609 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): VGF mRNA
Genes: VGF
Study 36462609 — Safety Biomarker (SAF): BDNF
Study 33199491 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34220720 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 32401718 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 35003725 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 32350016 — Surrogate Endpoint (SUR): Blood pressure
Study 35158461 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35763213 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 33156757 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32277781 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33667525 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study 33667525 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 34166799 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32211800 — Predictive Biomarker (PRD): TNS3 mRNA
Genes: TNS3; TEM6; TENS1; TPP
Study 33934514 — Surrogate Endpoint (SUR): Blood pressure
Study 32330093 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 33979096 — Predictive Biomarker (PRD): VCP mRNA
Genes: VCP
Study 36192617 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 36192617 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32164723 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32472526 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study 32750310 — Surrogate Endpoint (SUR): Blood pressure
Study 35678032 — Predictive Biomarker (PRD): SLCO1A2 mRNA
Genes: SLCO1A2; OATP; OATP1; OATP1A2; SLC21A3
Study 35236647 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35236647 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32913029 — Surrogate Endpoint (SUR): Blood pressure
Study 35674757 — Safety Biomarker (SAF): Hyaluronic acid
Study 36495879 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36495879 — Predictive Biomarker (PRD): Hormone receptor
Study 32701204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32701204 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32701204 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32701204 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 32701204 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32701204 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32701204 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 33806669 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 35277995 — Predictive Biomarker (PRD): GPR139 mRNA
Genes: GPR139; GPRG1; PGR3
Study 34684498 — Surrogate Endpoint (SUR): Blood pressure
Study 36372069 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32470486 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 33290975 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33290975 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35396709 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 36400597 — Surrogate Endpoint (SUR): Serum luteinizing hormone
Study 36400597 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32217498 — Predictive Biomarker (PRD): TSN mRNA
Genes: TSN